The Dark Side of Long COVID-19: Impaired Cardiac Function, Quality of Life and Functional Capacity in Egyptian Long COVID-19 Patients
Ghadeer Abdelhafez Abdellatef Assal , Lamyaa Said El Bagoury , Prithwish Banerje , Yasser
Alaaeldin Mahmoud Abdellatif , Mona
Mostafa Rayan , Mohamed Farouk Allam
QJM: An International Journal of Medicine, Volume 118,
Issue Supplement_1, November 2025, hcaf224.078, https://doi.org/10.1093/qjmed/hcaf224.078
Abstract
Introduction. Long COVID-19 remains a complex health issue, with
dyspnea being one of the most prevalent symptoms. While most studies have
focused on its respiratory effects, its impact on cardiac function has received
less attention. This study aimed to assess how Long COVID-19 affects functional
capacity, cardiac function, and quality of life, providing a more comprehensive
understanding of its long-term consequences.
Methodology. The present study included 34 patients with Long
COVID- 19 who presented to Ain Shams University Hospitals (Cairo, Egypt)
between February 2022 and December 2022, at least four weeks after acute
COVID-19 infection. Patients exhibited varying degrees of initial disease
severity and reported symptoms such as dyspnea, chest pain, or palpitations.
Each participant underwent assessment using the Euro Quality of Life (EuroQol)
questionnaire, the 6- Minute Walk Test (6MWT), and echocardiography, including
two-dimensional left ventricular global longitudinal strain (GLS).
Results. Dyspnea was the most frequently reported
cardiovascular symptom, affecting 94.1% of patients, followed by chest pain
(67.6%) and palpitations (64.7%). The study population ranged in age from 18 to
67 years, with a predominance of females (85.3%). Only 2.9% were smokers, while
76.5% had pre-existing chronic conditions, most commonly atopy and vitamin D
deficiency. All patients reported a significantly decreased quality of life
compared to their pre-COVID-19 state (P < 0.001). Notably, 25% of participants
exhibited oxygen desaturation during the 6MWT, and 20.6% had impaired GLS
(defined as GLS above -16%). Patients with abnormal GLS were more likely to
have diabetes mellitus, a history of oxygen therapy during acute infection, and
less colchicine use compared to those with normal GLS (GLS below -18%).
Furthermore, abnormal GLS correlated with reduced walking distance in the 6MWT,
diastolic dysfunction, and impaired right ventricular (RV) systolic function,
as indicated by decreased tricuspid annular plane systolic excursion (TAPSE)
measurements.
Conclusion. Long COVID-19 significantly affects functional
capacity and quality of life. A subset of patients demonstrates subtle left
ventricular systolic dysfunction, as evidenced by impaired GLS despite a
preserved ejection fraction. These findings highlight the need for long-term
cardiac follow-up and potential management strategies to address lingering
cardiovascular impairments in Long COVID-19 patients.
Keywords. Long COVID-19, Dyspnea, Quality of life, 6-Minute Walk Test, Echocardiography, Global longitudinal strain, EuroQOL
questionnaire, Post-COVID syndrome